Aurobindo Pharma Fundamental Analysis
AUROPHARMA
1777.130.10 (-1.67%)
Last updated on 14 Nov, 2026 | 14:59 IST
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Aurobindo Pharma Fundamentals
P/E Ratio
26.37
P/B Ratio
2.67
Div. Yield
0.22
Sector P/E
41.18
Sector P/B
2.49
Sec. Div. Yield
0.53
Aurobindo Pharma Fundamentals is currently trading with a P/E Ratio of 26.37, compared to the sector average of 41.18. Its P/B Ratio stands at 2.67, while the sector’s is 2.49. In terms of returns, the stock offers a Dividend Yield of 0.22%, which is than the sector’s 0.53%.
Aurobindo Pharma Score Card
Price
Expensive
Growth
Poor
Quality
Good
Management
Good
On its scorecard, Aurobindo Pharma reflects: Price – Expensive, Growth – Poor, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
Aurobindo Pharma Associated Pages
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in AUROPHARMA
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Or Download Choice FinX App
Invest in AUROPHARMA
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade